RT Journal Article
SR Electronic
T1 Predictors for participation in DNA self-sampling of childhood cancer survivors in Switzerland
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.25.21257796
DO 10.1101/2021.05.25.21257796
A1 Waespe, Nicolas
A1 Strebel, Sven
A1 Marino, Denis
A1 Mattiello, Veneranda
A1 Muet, Fanny
A1 Nava, Tiago
A1 Schindera, Christina
A1 Belle, Fabien N.
A1 Mader, Luzius
A1 Spoerri, Adrian
A1 Kuehni, Claudia E.
A1 Ansari, Marc
YR 2021
UL http://medrxiv.org/content/early/2021/05/27/2021.05.25.21257796.abstract
AB Research on germline genetic variants relies on a sufficient number of eligible participants which is difficult to achieve for rare diseases such as childhood cancer. With self-collection kits using saliva or buccal swabs, participants can contribute genetic samples conveniently from their home. We identified determinants of participation in DNA self-collection in this cross-sectional study.We invited 928 childhood cancer survivors in Switzerland with a median age of 26.5 years (interquartile range 18.8-36.5), of which 463 (50%) participated. Foreign nationality (odds ratio [OR] 0.5, 95%-confidence interval [CI] 0.4-0.7), survivors aged 30-39 years at study versus other age groups (OR 0.5, CI 0.4-0.8), and those with a known cancer predisposition syndrome (OR 0.5, CI 0.3-1.0) participated less. Survivors with a second primary neoplasm (OR 1.9, CI 1.0-3.8) or those living in a French or Italian speaking region (OR 1.3, 1.0-1.8) tended to participate more.We showed that half of survivors participate in germline DNA self-sampling relying completely on mailing of sample kits. Foreign nationality, age 30-39 years, and cancer predisposition syndromes were associated with less participation. More targeted recruitment strategies may be advocated for these subgroups. To increase participation in DNA self-sampling, understanding and perceptions of survivors need to be better understood.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04702321Funding StatementThis study is supported by the CANSEARCH Foundation for BISKIDS, the host biobank BaHOP, the research study GECCOS, and salary support to Nicolas Waespe and Sven Strebel. Further funding comes from the Swiss National Science Foundation (31BL30_185396), and Swiss Cancer Research (KFS-4722-02-2019, KLS/KFS-4825-01-2019). The funding bodies have no role in the design of the study and collection, analysis, and interpretation of data and in writing this manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Geneva Cantonal Commission for Research Ethics has approved the BaHOP biobank (approval PB_2017-00533) and the Genetic Risks for Childhood Cancer Complications Switzerland (GECCOS) study, which will utilize the samples (approval 2020-01723).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDatasets are available from the corresponding author on reasonable request for specific projects.BaHOPBiobank for Hematology and Oncology in PediatricsBISKIDSGermline DNA Biobank Switzerland for Childhood Cancer and Blood DisordersCCSChildhood cancer survivorCNSCentral nervous systemCPSCancer predisposition syndromeDNADeoxyribonucleic acidGECCOSGenetic risks for childhood cancer complications SwitzerlandHSCTHematopoietic stem cell transplantationICCC-3International Classification of Childhood Cancer, third editionISPMInstitute of Social and Preventive MedicineSCCRSwiss Childhood Cancer RegistrySPNSecond primary neoplasm